Connect with us

Technology

Ten63 Therapeutics Launches BEYOND-Alpha, with Chugai Pharmaceutical as First Participant

Published

on

Early adopter program aims to scale Ten63’s BEYOND platform across challenging pharmaceutical targets

DURHAM, N.C., Nov. 18, 2026 /PRNewswire/ — Ten63 Therapeutics, Inc. (“Ten63”) today announced the launch of BEYOND-Alpha, an early adopter program through which select pharmaceutical companies will work with Ten63 to apply its BEYOND computational drug design platform. Chugai Pharmaceutical Co., Ltd. (“Chugai”) is the first pharmaceutical company to participate in the BEYOND-Alpha program.

Through BEYOND-Alpha, a limited number of early participants will work with Ten63 to apply BEYOND across challenging targets. BEYOND-Alpha is designed to allow Ten63’s computational design infrastructure to operate across multiple drug discovery programs in parallel.

“AI changes the economics of drug discovery because computational molecular design can scale in a way conventional experimental discovery cannot,” said Marcel Frenkel, Ph.D., Co-Founder and CEO of Ten63 Therapeutics. “Scale isn’t the only advantage. BEYOND is designed to tackle targets historically considered undruggable or intractable.”

As part of BEYOND-Alpha, Ten63 will apply its proprietary computational drug design platform, BEYOND, to Chugai-nominated targets that present challenges for conventional small-molecule discovery approaches. Ten63 will generate and rank molecular structures designed against each target. Chugai will have the right to negotiate terms for the further research, development, and commercialization of molecules including the structures generated by Ten63 against each target, subject to the execution of a separate definitive agreement.

“Chugai is one of the most innovative drug discovery organizations in the world, with an exceptional track record of pursuing new science and challenging therapeutic targets. That makes them an ideal first participant in BEYOND-Alpha,” added Frenkel.

Chugai’s participation in BEYOND-Alpha expands on the investment from Chugai Venture Fund, the corporate venture arm of Chugai, in Ten63‘s strategic financing announced in February 2026. 

About BEYOND

BEYOND is Ten63’s computational drug design platform for generative chemistry, built to maintain accuracy across low-data and challenging targets. In recent prospective studies across diverse protein targets, BEYOND-generated designs achieved SPR-confirmed hit rates ranging from 11-75%, including against targets for which leading co-folding methods had previously produced few or no confirmed binders. Across these programs, hit identification was achieved by synthesizing and assaying fewer than 20 molecules per program. BEYOND combines high-fidelity physics-based simulation with AI, enabling Ten63 to search in excess of 100 trillion synthetically accessible molecules and design candidates against protein targets long regarded as intractable, including targets lacking conventional binding pockets.

About the BEYOND-Alpha Program

BEYOND-Alpha is Ten63’s early adopter drug design program, created to demonstrate the scalability of Ten63’s BEYOND platform across pharmaceutical discovery portfolios. It provides a limited number of pharmaceutical participants with the opportunity to apply BEYOND across challenging drug targets. Ten63 applies its computational design technology to generate and prioritize molecular structures against participant-nominated targets, enabling participants to evaluate multiple potential molecular starting points before determining whether to pursue broader development and licensing relationships.

About Ten63 Therapeutics

Ten63 is a frontier AI drug-discovery company spun out of Duke University and TTIC and headquartered in the Research Triangle, North Carolina. Ten63 is leveraging its BEYOND computational platform for generative chemistry to develop first- and best-in-class therapeutics. For more information, visit https://www.ten63tx.com/ and follow us on LinkedIn.

About Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group. Additional information is available at https://www.chugai-pharm.co.jp/english/

View original content to download multimedia:https://www.prnewswire.com/news-releases/ten63-therapeutics-launches-beyond-alpha-with-chugai-pharmaceutical-as-first-participant-302944186.html

SOURCE Ten63 Therapeutics

Continue Reading

Technology

Replit Launches Replit & Co., a New Creator Program Bringing B2B Voices Into the Era of the Self-Driving Company

Published

on

By

Replit marked the launch with an event this week featuring Marina Mogilko, known as “Silicon Valley Girl.”

The program brings together 45 B2B creators to show enterprise audiences how to put AI agents to work

SAN FRANCISCO, Nov. 18, 2026 /PRNewswire/ — Replit, the agentic software creation platform that enables anyone to build applications without learning to code, today announced Replit & Co., a new B2B creator program that brings together business and technology creators to demonstrate how enterprises can build software and put agents to work with Replit. The program supports Replit’s vision of the self-driving company, where people define goals and remain accountable while agents execute work within clear boundaries.

Replit & Co. launched with 45 creators, including Marina Mogilko, known as “Silicon Valley Girl”; April Little, named to the 2025 TIME100 Creators list; and Carly Taylor, engineering leader and founder of Rebel Data Science.

The program gives creators access to Replit’s product updates and opportunities to work directly with its team. Through content and demonstrations, creators can show their communities how to use Replit’s AI agents to build applications, automate workflows and get more done across their businesses.

“The people closest to the work usually have the best ideas about what needs to change. Our vision of the self-driving company is about making it easier for them to act on those ideas, with AI agents handling more of the execution,” said Haya Odeh, co-founder and Head of Design at Replit. “Replit & Co. brings that vision to business audiences through creators they already trust and learn from.”

As agents take on more of the execution, employees across companies can turn ideas into working software without waiting on traditional development cycles.

“Business audiences don’t need another prediction about AI. They need to see what it can actually do,” said Nick Silver, VP of Marketing at Replit. “We’re looking for creators who understand how businesses work and can show people how to solve real problems. The goal is for someone to watch a demo and think, ‘We could build that for our team.'”

Members of Replit & Co. receive Replit account benefits, regular product updates and opportunities to connect with Replit’s team and broader ecosystem. Additional opportunities include early access to new capabilities, member showcases, sessions with Replit leadership and co-branded events.

The program is open to creators with expertise in business, technology and related fields. Replit is looking for creators with credible voices and engaged audiences, not simply large followings. Applications are reviewed on a rolling basis.

About Replit

Replit is the agentic software creation platform that enables anyone to build applications without learning code. Founded in 2016, the company has more than 60 million users worldwide, including users at 85% of the Fortune 500. Teams at enterprises including Atlassian, Accenture, Adobe, and Databricks use Replit to build apps, and the company has partnerships with Google, Stripe, and Slack, among others. Replit is headquartered in San Francisco with offices in London and Tokyo.

Media Contact: press@replit.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/replit-launches-replit–co-a-new-creator-program-bringing-b2b-voices-into-the-era-of-the-self-driving-company-302944302.html

SOURCE Replit

Continue Reading

Technology

PEJU Introduces the PEJU Wine Fund: A Little Set Aside Each Month, to Enjoy Whenever the Moment Feels Right

Published

on

By

Rutherford’s PEJU Winery introduces the Wine Fund, or PEJU Bucks: $75 a month builds a balance to enjoy online, in the tasting room or on Club orders, with no commitment.

RUTHERFORD, Calif., Nov. 18, 2026 /PRNewswire-PRWeb/ — For $75 a month, with no club membership required, guests build a balance, spend it however they like – online, in the tasting room, or even on a Club order. Everyone calls it PEJU Bucks.

The Wine Fund is for people who want PEJU on their own terms.

PEJU Winery, the family-owned and female-led Napa Valley winery that has called Rutherford home for more than 40 years, today introduced the PEJU Wine Fund, a simple way for guests to stay close to PEJU entirely on their own terms. No wine is ever sent unless a guest asks for it.

Many wine lovers want a closer relationship with a winery, but not a standing commitment. The Wine Fund is not a club or a payment plan. It offers a steady monthly balance, real savings and full control, and it is there to enjoy year-round, not just when a club order is due. When it is time to celebrate, gather or simply open a good bottle, it’s already taken care of.

“PEJU Bucks is for people who want PEJU in their lives without being locked into anything or for current club members who want a more predictable spend,” said Nadia Kinkade, Senior Director of DTC Sales & Marketing, PEJU Winery. “Build it at your pace, spend it however you like, and enjoy savings every time you do.”

For guests who aren’t ready for a club, the Wine Fund is a warm, easy first step. They can stop anytime and keep everything they’ve set aside. For club members, it makes each shipment feel like something already planned for, not a surprise.

The PEJU Wine Fund is available now at peju.com/wine-fund, and the PEJU tasting room team is happy to help guests get started during their visit.

About PEJU Winery

For over 40 years, PEJU Winery has welcomed guests to its home in Rutherford, in the heart of Napa Valley. Tony and Herta “HB” Peju founded PEJU in 1983 and helped shape the warm, personal Wine Country visit so many guests enjoy today. The winery remains family-owned and female-led. Second-generation owners Lisa and Ariana Peju guide the winery alongside longtime winemaker Sara Fowler, caring for five estate vineyards across 515 acres. The Rutherford estate celebrates beauty in wine and art alike, with its whimsical 50-foot tower, lush gardens, a collection of sculpture, and a stained-glass window dating to 1906. Guests are invited to settle in and explore at their own pace through a variety of tastings and food pairings, with approachable wines made for sharing around the table and enjoying on every kind of occasion. Learn more at peju.com.

Media Contact

Holly Evans, PEJU Winery, 1 707-302-7412, hevans@peju.com, peju.com

View original content to download multimedia:https://www.prweb.com/releases/peju-introduces-the-peju-wine-fund-a-little-set-aside-each-month-to-enjoy-whenever-the-moment-feels-right-302944111.html

SOURCE PEJU Winery

Continue Reading

Technology

Advantage Technologies Named OpenText’s 2026 Reseller of the Year

Published

on

By

Advantage Technologies has been named OpenText’s 2026 Reseller of the Year.

NEW YORK, Nov. 18, 2026 /PRNewswire-PRWeb/ — Advantage Technologies, Inc., a provider of enterprise fax, cloud fax and AI-enabled document automation solutions, today announced that it has been named OpenText’s 2026 Reseller Partner of the Year. The recognition reflects Advantage’s expertise as an OpenText partner and its work helping organizations maintain reliable, business-critical communications while modernizing how documents are exchanged and processed.

“We’re constantly evaluating new technologies, including AI and automation, to understand where they can make a real, measurable difference in how our customers operate. We take the time to understand their business, recommend what makes sense, and stand behind our work.”

For nearly three decades, Advantage has helped organizations in healthcare, government, financial services, insurance, manufacturing and other industries manage secure, reliable document communications. Today, its work spans OpenText Fax (RightFax), cloud fax (hosted, SaaS and hybrid),, intelligent document processing and AI-enabled workflow automation.

“To me, this award is about the people who support our customers every day,” said Barry Malter, President of Advantage Technologies. “Our customers rely on these systems, and they need a partner who knows the technology and gives them a straight answer. We’re constantly evaluating new technologies, including AI and automation, to understand where they can make a real, measurable difference in how our customers operate. We take the time to understand their business, recommend what makes sense, and stand behind our work.”

“Congratulations to Advantage Technologies on winning the Partner of the Year at the 2026 OpenText Partner Awards. This achievement reflects the innovation, expertise and forward-thinking approach that make our partners such an important part of how we help clients solve complex challenges and get more value from technology. As the market evolves, our partners play a vital role in helping clients navigate change and embrace new possibilities. By combining our strengths, we can turn those possibilities into meaningful outcomes for clients and new avenues for growth. We’re proud to recognize Advantage Technologies’ success and look forward to what we can achieve together next.” — Joel Kremke, Senior Vice President, Worldwide Partner Alliances & Programs, OpenText.

The recognition comes as Advantage prepares to celebrate its 30th anniversary in 2027.

“Next year marks 30 years in business for Advantage,” Malter added. “You don’t stay in this business that long unless customers trust you to deliver. We have a great team that takes that responsibility personally, and I’m grateful to them, to our customers and to OpenText for their continued partnership.”

Media Contact

Brianna Wolcott, Advantage Technologies, 1 6467660757, bwolcott@atechnologies.com, Advantage Technologies

Twitter

View original content to download multimedia:https://www.prweb.com/releases/advantage-technologies-named-opentexts-2026-reseller-of-the-year-302944078.html

SOURCE Advantage Technologies

Continue Reading

Trending